Medicarpin 3-O-glucosideCAS# 52766-70-8 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 52766-70-8 | SDF | Download SDF |
PubChem ID | 23724664 | Appearance | Powder |
Formula | C22H24O9 | M.Wt | 432.42 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R,4S,5S,6R)-2-[[(6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
SMILES | COC1=CC2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)OC5C(C(C(C(O5)CO)O)O)O | ||
Standard InChIKey | PVEMGMOWXQUWRD-NJAOXFEXSA-N | ||
Standard InChI | InChI=1S/C22H24O9/c1-27-10-2-4-12-14-9-28-15-7-11(3-5-13(15)21(14)30-16(12)6-10)29-22-20(26)19(25)18(24)17(8-23)31-22/h2-7,14,17-26H,8-9H2,1H3/t14-,17+,18+,19-,20+,21-,22+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Medicarpin-3-O-glucoside, a phytoalexin, shows inhibition against the germination of G. intraradices spores and hyphal elongation. |
Medicarpin 3-O-glucoside Dilution Calculator
Medicarpin 3-O-glucoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3126 mL | 11.5628 mL | 23.1257 mL | 46.2513 mL | 57.8142 mL |
5 mM | 0.4625 mL | 2.3126 mL | 4.6251 mL | 9.2503 mL | 11.5628 mL |
10 mM | 0.2313 mL | 1.1563 mL | 2.3126 mL | 4.6251 mL | 5.7814 mL |
50 mM | 0.0463 mL | 0.2313 mL | 0.4625 mL | 0.925 mL | 1.1563 mL |
100 mM | 0.0231 mL | 0.1156 mL | 0.2313 mL | 0.4625 mL | 0.5781 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- beta-Asarone
Catalog No.:BCN5685
CAS No.:5273-86-9
- Isoelemicin
Catalog No.:BCN4760
CAS No.:5273-85-8
- Scillascillin
Catalog No.:BCN5684
CAS No.:52706-07-7
- Ginsenoside Rd
Catalog No.:BCN1074
CAS No.:52705-93-8
- Herbacetin
Catalog No.:BCN1268
CAS No.:527-95-7
- Azomycin
Catalog No.:BCC5315
CAS No.:527-73-1
- Sodium Gluconate
Catalog No.:BCC4721
CAS No.:527-07-1
- D-Penylalaninol
Catalog No.:BCC2715
CAS No.:5267-64-1
- A23187, free acid
Catalog No.:BCC6980
CAS No.:52665-69-7
- Kirenol
Catalog No.:BCN5682
CAS No.:52659-56-0
- Anisodine
Catalog No.:BCN1868
CAS No.:52646-92-1
- Siegeskaurolic acid
Catalog No.:BCN6982
CAS No.:52645-97-3
- PHA 568487
Catalog No.:BCC7574
CAS No.:527680-57-5
- H-D-Phe(3,4-DiCl)-OH
Catalog No.:BCC3179
CAS No.:52794-98-6
- H-Phe(3,4-DiCl)-OH
Catalog No.:BCC3178
CAS No.:52794-99-7
- Magnolol
Catalog No.:BCN5687
CAS No.:528-43-8
- Fisetin
Catalog No.:BCN5024
CAS No.:528-48-3
- Delphinidin chloride
Catalog No.:BCN3015
CAS No.:528-53-0
- Cyanidin Chloride
Catalog No.:BCN1231
CAS No.:528-58-5
- (±)-Galgravin
Catalog No.:BCN8283
CAS No.:528-63-2
- Isobavachromene
Catalog No.:BCN3192
CAS No.:52801-22-6
- L-Quisqualic acid
Catalog No.:BCC6568
CAS No.:52809-07-1
- Dalbergiphenol
Catalog No.:BCN7451
CAS No.:52811-31-1
- Cearoin
Catalog No.:BCN7772
CAS No.:52811-37-7
The defense response elicited by the pathogen Rhizoctonia solani is suppressed by colonization of the AM-fungus Glomus intraradices.[Pubmed:11297789]
Plant Sci. 2001 Apr;160(5):925-932.
Defense responses of alfalfa roots to the pathogenic fungus Rhizoctonia solani were reduced significantly in roots simultaneously infected with the vesicular arbuscular mycorrhizal (AM) fungus Glomus intraradices. R. solani induced five- to tenfold increases in the steady-state levels of chalcone isomerase and isoflavone reductase mRNAs a doubling of root peroxidase activity and a marked autofluorescence in the infected tissue. These changes were inhibited by the presence of G. intraradices. Interestingly, germination of G. intraradices spores and hyphal elongation were sensitive to low concentrations (2 microM) of medicarpin-3-O-glucoside, an isoflavonoid phytoalexin that accumulated both in roots colonized by the pathogenic fungus as well as in AM-treated roots receiving high P, where no colonization by the beneficial fungus occurred. These data support the hypothesis that during early stages of colonization by G. intraradices, suppression of defense-related properties is associated with the successful establishment of AM symbiosis.
Isoflavonoids as wound healing agents from Ononidis Radix.[Pubmed:28989011]
J Ethnopharmacol. 2018 Jan 30;211:384-393.
ETHNOPHARMACOLOGICAL RELEVANCE: Dried roots of Ononis spinosa L. are traditionally used for their diuretic, anti-inflammatory and wound healing effects. AIM OF THE STUDY: Isolation of the bioactive compounds of Ononis spinosa L. subsp. leiosperma (Boiss.) Sirj. MATERIALS AND METHODS: Ethyl acetate extract prepared from the roots of Ononis spinosa L. subsp. leiosperma (Boiss.) Sirj. was subjected to silica gel column. The fractions were tested for their wound healing and anti-inflammatory activities. Linear incision and circular excision wound models and hydroxypyroline estimation assay were used for the wound healing activity. Carrageenan-induced hind paw edema, TPA-induced ear edema and acetic acid-induced increase in capillary permeability tests as acute inflammation; FCA-induced arthritis as chronic inflammation models were used for the assessment of anti-inflammatory activity. Antioxidant capacities of the fractions were tested using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, 2,2-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid (ABTS) scavenging activity assay, reducing power assay and hydroxyl radical (OH(-)) scavenging assay. The isolation procedure was continued with the active fraction (Fr-E5). RESULTS: Fr-E5 exhibited remarkable wound healing activity with the 33.4% tensile strength value on the linear incision wound model and 51.4% reduction of the wound area at the day 12 on the circular excision wound model. Hydroxyproline content of the tissue treated by Fr-E5 was found to be 30.9 +/- 0.72mug/mg. Acetic acid induced increase in capillary permeability test results revealed that Fr-E5 inhibited inflammation by the value of 40.3%. Fr-E5 showed 28.1-32.2% inhibition in carrageenan-induced hind paw edema test while did not possess activity on TPA-induced ear edema and FCA-induced arthritis models. Trifolirhizin, ononin, medicarpin-3-O-glucoside, onogenin-7-O-glucoside and sativanone-7-O-glucoside were isolated from Fr-E5 and tested for their wound healing activities using by measuring their inhibition of hyaluronidase, collagenase and elastase enzymes. Ononin and sativanone-7-O-glucoside inhibited hyaluronidase and elastase enzymes by 31.66% and 41.75%; 45.58% and 46.88% values respectively at the dose of 100mug/mL. CONCLUSION: Among five isolated compounds, ononin and sativanone-7-O-glucoside were found to inhibit hyaluronidase and elastase enzymes. According to the results, these compounds may majorly be responsible for the wound healing activity of the extract.